STOCKHOLM, SWEDEN, May 13, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has reached a new milestone with 10,000 patients treated with the inn… [+2450 chars]...
Read moreSTOCKHOLM, SWEDEN, June 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has carried out a directed share issue through an accelerated bookbui… [+3628 chars]...
Read moreSTOCKHOLM, SWEDEN May 26, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has resumed the inclusion of patients to the clinical … [+2400 chars]...
Read moreSTOCKHOLM, SWEDEN May 7, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will attend the EASL Congress 2025 in Amsterdam, May 71… [+3379 chars]...
Read moreSTOCKHOLM, SWEDEN May 15, 2025. Karolinska Development AB (publ) (Karolinska Development or the Company) held the Annual General Meeting on May 15, 2025. The shareholders have had the right to exerci… [+8334 chars]...
Read more